(66 days)
Not Found
No
The summary describes a standard contact lens with no mention of AI or ML technology.
No
The device is indicated for the correction of visual acuity in persons with non-diseased eyes, not for treating a disease or condition.
No
The device is a contact lens intended for the correction of visual acuity, which is a treatment or correction, not a diagnosis.
No
The device is a physical contact lens made of a hydrophilic polymer, not a software application.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body (like blood, urine, or tissue) to provide information for diagnosis, monitoring, or screening.
- Device Function: The LL-55 contact lenses are designed to correct visual acuity by being placed directly on the surface of the eye. They do not analyze any bodily specimens.
- Intended Use: The intended use clearly states correction of visual acuity in persons with non-diseased eyes. This is a therapeutic/corrective function, not a diagnostic one.
Therefore, based on the provided information, the LL-55 contact lens is a medical device, but it falls under a different category than In Vitro Diagnostics.
N/A
Intended Use / Indications for Use
LL-55 (methafilcon A) Soft Hydrophilic Contact Lenses are indicated for daily wear for the correction of visual acuity in not aphakic persons with non-diseased eyes that are myopic or hyperopic and exhibit astigmatism of 2.00D or less that does not interfere with visual acuity.
Product codes (comma separated list FDA assigned to the subject device)
86 LPL
Device Description
The LL-55 contact lenses are available as lathe cut spherical lens. The lens material (methafilcon A) is a hydrophilic polymer of hydroxyethylmethacrylate and methacrylic acid.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
eyes
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Clinical tests not performed; lenses remain unchanged from approved Premarket 510(k) Notification K941877.
Non Clinical tests and results:
The final product lenses will be processed through packaging, sealing, sterilization and staged for QC release in same manner as currently established and validated. The only change to the process will be the elimination of Biological Indicators. This submission supports use of physical parameters of sterilization cycle to meet specifications as the basis for sterility release mechanism.
Validation of the Steam Sterilization Process:
Validation of the steam sterilization process demonstrated that the steam steellizer is capable of achieving more than a 10 sterility assurance level (SAL) upon completion of a calculated exposure time of twenty (20) minutes and an exposure temperature of 121 degrees C on normal finished product lenses.
Product Bioburden Monitoring:
Results obtained monthly over a 5 month period have determined that bioburden of product in production is well controlled. Presterilization bloburden results are consistently significantly below both 1000 vegetative CFU and 40 spore forming CFU. Each month average CFU per presterilized product unit for the 5 months from July 1997 to November 1997 is low; counts range from a high of 294 to a low of 29 vegetative CFU and less than 1 sporeforming CFU. The process used to determine bioburden has been validation included assessment of the adequacy of the technique used to remove micro-organisms from the final lens product, assessment of the adequacy of the technique used to enumerate removed micro-organisms, including micro-biological counting techniques and culture conditions; and establishment of the recovery efficiency for the method used in order that the correction factor be calculated.
Laminar Flow Workstation Bioburden Level:
Settle plates are routinely used in the manufacturing facility laminar flow workstations to monitor the airborne bioburden. Results are consistently low. Surface touch plates are used to routinely sample bioburden levels on workstation surfaces. Results are consistently low.
Calibration/ Certification of Relevant Equipment:
The steam sterilizer was calibrated to demonstrate that the apparatus is operating within manufacturer design specifications. The sterilizer successfully demonstrated its capability to regulate temperature. The pressure gauge on the stenlizer also successfully demonstrated it's ability to display and record pressure. Upon performing the zero and span calibration procedures on the data logger all output temperatures from the 10 validation thermocouple readings deviated less than 1 degree C from the setpoint. The pressure readings were monitored and pressure was held to 15 psi +/- 0.5 psi during the timing portion of the cycle. Annual calibration of steam stenlizer is performed to verify consistent parameter measurement recordings. Additionally annual sterilizer validations are performed to ensure consistent operations of sterilizer to specifications and to verify adequacy of cycle times. Recent validation results demonstrated that the sterilizer is in compliance with operating specifications and cycle time exceeds time necessary to achieve 100 sterility assurance level (SAL). To ensure consistent operating efficiency, annual certification of the laminar air flow workstations is performed. Recent certification results demonstrated that the laminar air flow workstations were in compliance with Federal Standard 209E to Class 100 requirements.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 886.5925 Soft (hydrophilic) contact lens.
(a)
Identification. A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage. The device is made of various polymer materials the main polymer molecules of which absorb or attract a certain volume (percentage) of water.(b)
Classification. (1) Class II if the device is intended for daily wear only.(2) Class III if the device is intended for extended wear.
(c)
Date PMA or notice of completion of a PDP is required. As of May 28, 1976, an approval under section 515 of the act is required before a device described in paragraph (b)(2) of this section may be commercially distributed. See § 886.3.
0
K 980218
Biocompatibles Evecare Inc. Parametric Release 510(k) methafilcon A hydrophilic contact lenses
MAR 2 3 1998
SAFETY AND EFFECTIVENESS SUMMARY
| 1. | Name and
address of
submitter | Biocompatibles Eyecare Inc.
1215 Boissevain Avenue
Norfolk VA USA 23507
Contact Person: Lisa Hahn |
|----|-------------------------------------|------------------------------------------------------------------------------------------------------------|
| | | Telephone number: 800-225-3069 or 757-664-2421 |
| | | Date summary prepared: January 15, 1998 |
| 2. | Identification of
Device | Trade Name: LL-55 (methafilcon A) Soft Contact Lens |
| | | Common or Usual Name: Soft (hydrophilic) Contact Lens (daily wear)
Classification: Group II |
| 3. | Predicate Device | LL-55 (methafilcon A) Contact Lens |
র্থ Description of Device
The LL-55 contact lenses are available as lathe cut spherical lens. The lens material (methafilcon A) is a hydrophilic polymer of hydroxyethylmethacrylate and methacrylic acid.
5. Intended Use (indications)
LL-55 (methafilcon A) Soft Hydrophilic Contact Lenses are indicated for daily wear for the correction of visual acuity in not aphakic persons with non-diseased eyes that are myopic or hyperopic and exhibit astigmatism of 2.00D or less that does not interfere with visual acuity.
Ga Characteristics comparison of predicate to this device
Design, material, and chemical composition remain unchanged from those approved in Premarket 510(k) Notification K941877
Sb . Clinical tests and results
Not performed; lenses remain unchanged from approved Premarket 510(k) Notfication K941877.
6c. Non Clinical tests and results
The final product lenses will be processed through packaging, sealing, sterilization and staged for QC release in same manner as currently established and validated. The only change to the process will be the elimination of Biological Indicators. This submission supports use of physical parameters of sterilization cycle to meet specifications as the basis for sterility release mechanism.
1
Biocompatibles Eyecare Inc. Parametric Release 510(k) methafilcon A hydrophilic contact lenses
6c 1. Validation of the Steam Sterilization Process:
Validation of the steam sterilization process demonstrated that the steam steellizer is capable of achieving more than a 10 sterility assurance level (SAL) upon completion of a calculated exposure time of twenty (20) minutes and an exposure temperature of 121° C on normal finished product lenses.
6c 2. Product Bioburden Monitorina
Results obtained monthly over a 5 month period have determined that bioburden of product in production is well controlled. Presterilization bloburden results are consistently significantly below both 1000 vegetative CFU and 40 spore forming CFU. Each month average CFU per presterilized product unit for the 5 months from July 1997 to November 1997 is low; counts range from a high of 294 to a low of 29 vegetative CFU and less than 1 sporeforming CFU.
The process used to determine bioburden has been validation included assessment of the adequacy of the technique used to remove micro-organisms from the final lens product, assessment of the adequacy of the technique used to enumerate removed micro-organisms, including micro-biological counting techniques and culture conditions; and establishment of the recovery efficiency for the method used in order that the correction factor be calculated.
6c 3. Laminar Flow Workstation Bioburden Level
Settle plates are routinely used in the manufacturing facility laminar flow workstations to monitor the airborne bioburden. Results are consistently low.
Surface touch plates are used to routinely sample bioburden levels on workstation surfaces. Results are consistently low.
6c 4. Calibration/ Certification of Relevant Equipment
The steam sterilizer was calibrated to demonstrate that the apparatus is operating within manufacturer design specifications. The sterilizer successfully demonstrated its capability to regulate temperature. The pressure gauge on the stenlizer also successfully demonstrated it's ability to display and record pressure. The
Upon performing the zero and span calibration procedures on the data logger all output temperatures from the 10 validation thermocouple readings deviated less than 1°C from the setpoint.
The pressure readings were monitored and pressure was held to 15 psi ± 0.5 psi during the timing portion of the cycle.
Annual calibration of steam stenlizer is performed to verify consistent parameter measurement recordings. Additionally annual sterilizer validations are performed to Summary of Safety and Effectiveness 2
2
Biocompatibles Eyecare Inc. Parametric Release 510(k) methafilcon A hydrophilic contact lenses
ensure consistent operations of sterilizer to specifications and to verify adequacy of cycle times. Recent validation results demonstrated that the sterilizer is in compliance with operating specifications and cycle time exceeds time necessary to achieve 100 sterility assurance level (SAL ).
To ensure consistent operating efficiency, annual certification of the laminar air flow workstations is performed. Recent certification results demonstrated that the laminar air flow workstations were in compliance with Federal Standard 209E to Class 100 requirements.
3
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three curved lines representing its wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular pattern around the eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAR 2 3 1998
Ms. Lisa Hahn Director of Regulatory Affairs Biocompatibles Eyecare, Inc. 1215 Boissevain Avenue Norfolk, VA 23507
Re: K980218
Trade Name: LL-55 (methafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear (Parametric release) Regulatory Class: II Product Code: 86 LPL Dated: January 15, 1998 Received: January 16, 1998
Dear Ms. Hahn:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
4
Page 2 - Ms. Lisa Hahn
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or at (301) 443-6597.
Sincerely yours,
Alberl Rosenthal
A. Ralph Rosenthal, M.D. Director Division of Ophthalmic Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
510(K) Number : K980218
LL-55 (methafilcon A) Daily Wear Contact Lens Device Name:
Indication for use:
LL-55 (methafilcon A) Soft Hydrophilic Contact Lenses are indicated for daily wear for the correction of visual acuity in not aphakic persons with non-diseased eyes that are myopic or hyperopic and exhibit astigmatism of 2.00D or less that does not interfere with visual acuity.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of the CDRH, Office of Device Evaluation (ODE)
Myro Smith
(Division Sign-Off)
Division of Ophthalmic Devices 510(k) Number_K 9802 18
Prescription Use X
OR
Over the counter use
(Optional format 1-2-96)